247 related articles for article (PubMed ID: 21954839)
1. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.
Mazzini L; Mareschi K; Ferrero I; Miglioretti M; Stecco A; Servo S; Carriero A; Monaco F; Fagioli F
Cytotherapy; 2012 Jan; 14(1):56-60. PubMed ID: 21954839
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial.
Mazzini L; Ferrero I; Luparello V; Rustichelli D; Gunetti M; Mareschi K; Testa L; Stecco A; Tarletti R; Miglioretti M; Fava E; Nasuelli N; Cisari C; Massara M; Vercelli R; Oggioni GD; Carriero A; Cantello R; Monaco F; Fagioli F
Exp Neurol; 2010 May; 223(1):229-37. PubMed ID: 19682989
[TBL] [Abstract][Full Text] [Related]
3. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
5. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS.
Staff NP; Madigan NN; Morris J; Jentoft M; Sorenson EJ; Butler G; Gastineau D; Dietz A; Windebank AJ
Neurology; 2016 Nov; 87(21):2230-2234. PubMed ID: 27784774
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
Karussis D; Karageorgiou C; Vaknin-Dembinsky A; Gowda-Kurkalli B; Gomori JM; Kassis I; Bulte JW; Petrou P; Ben-Hur T; Abramsky O; Slavin S
Arch Neurol; 2010 Oct; 67(10):1187-94. PubMed ID: 20937945
[TBL] [Abstract][Full Text] [Related]
7. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis.
Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Boccaletti R; Testa L; Livigni S; Fagioli F
Neurol Res; 2006 Jul; 28(5):523-6. PubMed ID: 16808883
[TBL] [Abstract][Full Text] [Related]
8. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
[TBL] [Abstract][Full Text] [Related]
9. Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.
Mazzini L; Gelati M; Profico DC; Sorarù G; Ferrari D; Copetti M; Muzi G; Ricciolini C; Carletti S; Giorgi C; Spera C; Frondizi D; Masiero S; Stecco A; Cisari C; Bersano E; De Marchi F; Sarnelli MF; Querin G; Cantello R; Petruzzelli F; Maglione A; Zalfa C; Binda E; Visioli A; Trombetta D; Torres B; Bernardini L; Gaiani A; Massara M; Paolucci S; Boulis NM; Vescovi AL;
Stem Cells Transl Med; 2019 Sep; 8(9):887-897. PubMed ID: 31104357
[TBL] [Abstract][Full Text] [Related]
10. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.
Deda H; Inci MC; Kürekçi AE; Sav A; Kayihan K; Ozgün E; Ustünsoy GE; Kocabay S
Cytotherapy; 2009; 11(1):18-25. PubMed ID: 19012065
[TBL] [Abstract][Full Text] [Related]
11. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
Uccelli A; Laroni A; Brundin L; Clanet M; Fernandez O; Nabavi SM; Muraro PA; Oliveri RS; Radue EW; Sellner J; Soelberg Sorensen P; Sormani MP; Wuerfel JT; Battaglia MA; Freedman MS;
Trials; 2019 May; 20(1):263. PubMed ID: 31072380
[TBL] [Abstract][Full Text] [Related]
12. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis.
Petrou P; Kassis I; Yaghmour NE; Ginzberg A; Karussis D
Front Biosci (Landmark Ed); 2021 Oct; 26(10):693-706. PubMed ID: 34719198
[No Abstract] [Full Text] [Related]
13. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
Syková E; Rychmach P; Drahorádová I; Konrádová Š; Růžičková K; Voříšek I; Forostyak S; Homola A; Bojar M
Cell Transplant; 2017 Apr; 26(4):647-658. PubMed ID: 27938483
[TBL] [Abstract][Full Text] [Related]
14. Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis.
De Marchi F; Mareschi K; Ferrero I; Cantello R; Fagioli F; Mazzini L
Cytotherapy; 2023 Aug; 25(8):798-802. PubMed ID: 36931995
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study.
Blanquer M; Moraleda JM; Iniesta F; Gómez-Espuch J; Meca-Lallana J; Villaverde R; Pérez-Espejo MÁ; Ruíz-López FJ; García Santos JM; Bleda P; Izura V; Sáez M; De Mingo P; Vivancos L; Carles R; Jiménez J; Hernández J; Guardiola J; Del Rio ST; Antúnez C; De la Rosa P; Majado MJ; Sánchez-Salinas A; López J; Martínez-Lage JF; Martínez S
Stem Cells; 2012 Jun; 30(6):1277-85. PubMed ID: 22415951
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
Prabhakar S; Marwaha N; Lal V; Sharma RR; Rajan R; Khandelwal N
Neurol India; 2012; 60(5):465-9. PubMed ID: 23135021
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic MRI changes in the spine and spinal cord after surgical stem cell grafting in patients with definite amyotrophic lateral sclerosis: post-infusion injuries are unrelated with clinical impairment.
García Santos JM; Blanquer M; Torres del Río S; Iniesta F; Espuch JG; Pérez-Espejo MÁ; Martínez S; Moraleda JM
Magn Reson Imaging; 2013 Oct; 31(8):1298-308. PubMed ID: 23810205
[TBL] [Abstract][Full Text] [Related]
18. Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis: an Original Study.
Barczewska M; Maksymowicz S; Zdolińska-Malinowska I; Siwek T; Grudniak M
Stem Cell Rev Rep; 2020 Oct; 16(5):922-932. PubMed ID: 32725316
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy.
Dahbour S; Jamali F; Alhattab D; Al-Radaideh A; Ababneh O; Al-Ryalat N; Al-Bdour M; Hourani B; Msallam M; Rasheed M; Huneiti A; Bahou Y; Tarawneh E; Awidi A
CNS Neurosci Ther; 2017 Nov; 23(11):866-874. PubMed ID: 28961381
[TBL] [Abstract][Full Text] [Related]
20. Stem cell treatment in Amyotrophic Lateral Sclerosis.
Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
